DANIA HUDHUD

Allopathic & Osteopathic Physicians|Internal Medicine BALTIMORE, MD NPI 1376993469

General Payments — all program years on this page

$1,331.60

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $485.69 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $485.6921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $108.461
2022 $122.841
2023 $614.619
2024 $485.6921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078782368 Janssen Biotech, Inc. $23.75 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078782753 Janssen Biotech, Inc. $22.28 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078783839 Janssen Biotech, Inc. $17.76 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101178448 Celgene Corporation $27.02 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101178466 Celgene Corporation $26.13 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101178488 Celgene Corporation $17.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103950072 ABBVIE INC. $18.13 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103950074 ABBVIE INC. $22.04 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113632286 Intercept Pharmaceuticals, Inc. $24.96 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131452966 PFIZER INC. $19.26 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131505242 PFIZER INC. $17.65 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131507952 PFIZER INC. $20.32 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131511013 PFIZER INC. $22.12 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131562781 PFIZER INC. $22.12 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136140119 Lilly USA, LLC $27.19 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136270610 Organon Llc $20.57 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137581350 Takeda Pharmaceuticals U.S.A., Inc. $20.14 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137581353 Takeda Pharmaceuticals U.S.A., Inc. $28.80 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137581357 Takeda Pharmaceuticals U.S.A., Inc. $44.34 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151074399 Phathom Pharmaceuticals, Inc. $21.51 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153567470 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.42 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.